- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amy Chen
- Andy DiAntonio
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charly Gilfoil
- Corey Davis
- Dania Douglas
- Daniel Young
- daryln
- David Machledt
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola Carrión
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Kasey Nichols
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Lisa Munoz
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- April 5, 2023
FAQ: Insurance Coverage for Pharmacy-Dispensed Medication Abortion
Read moreThe U.S. Food and Drug Administration (FDA) announced new changes to the mifepristone Risk Evaluation and Mitigation Strategy (REMS) in January 2023, opening the door to the expansion of medication abortion access through pharmacist dispensing. However, equitable abortion access under this model requires intentional benefit design in order to…
- April 3, 2023
National Health Law Program Comments on the DEA’s Proposed Rule on Telemedicine Prescribing of Controlled Medications
Read moreThe National Health Law Program (NHeLP) submitted comments on the Drug Enforcement Administration's (DEA) Notice of Proposed Rulemaking, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation." NHeLP believes that all people should have access to the health care…
- February 2, 2023
NHeLP Comments on Essential Health Benefits (EHB) Request for Information (RFI)
Read moreNHeLP submitted comments in response to the HHS' Request for Information (RFI) regarding coverage of Essential Health Benefits (EHB) in the private health insurance market. The comments highlight the need to provide guidance to states to ensure consumers have appropriate information about EHB coverage requirements. In addition, NHeLP underscores…
- November 1, 2022
Joint comment letter: Temporary Increase in Federal Medical Assistance Percentage (FMAP) in Response to the COVID–19 Public Health Emergency (PHE); Reopening of Public Comment Period
Read moreIn the last days of the Trump administration, the Centers for Medicare & Medicaid Services (CMS) finalized an Interim Final Rule (IFR) that creates exceptions to the Medicaid continuous coverage requirements in the Families First Coronavirus Response Act. The IFR allows states to reduce benefits and terminate eligibility in…
- October 18, 2022
Model Contraceptive Equity Act: Legislative Language and Issue Brief
Read moreUpdated October 2023. This paper begins with model legislative language that can serve as a template for state advocates seeking to expand contraceptive coverage. The paper concludes with an issue brief explaining the provisions within the Model Contraceptive Equity Act and how they advance equitable access to contraceptive services…
- August 19, 2022
NHeLP Letter to CCIIO Director, Ellen Montz – Re: Request for Modifications to the Federal Prescription Drug and Maternity Care Essential Health Benefit Standards
Read moreDespite improvements in coverage of Essential Health Benefits (EHB) since the enactment of the Affordable Care Act, significant gaps remain in access to care in various categories of service. In this follow-up letter to leadership at the Center for Consumer Information and Insurance Oversight (CCIIO), NHeLP urges the Department…
